• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • English
    Chinese
    French
    Hindi

    Renal Disease Market

    ID: 2289
    157 Pages
    Research Team
    02/2021

    Renal Disease Market Research Report Information by Disease Type (Chronic Kidney Disease, End-Stage Renal Disease), by Treatment Type (Dialysis, Medication, Kidney Transplantation), by End User (Dialysis Centers, Hospital & Clinics, Research and Academic Institutes), and By Region (North America, Europe, Asia-Pacific, and Rest of The World) - Forecast Till 2032

    Share:
    ReportInfographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License

    Market Summary

    Research Methodology on Renal Disease Market


    1. Introduction


    The purpose of this research is to assess the impact of renal disease on the global market. The research question is, what are the factors influencing the development of renal disease markets worldwide? Specifically, we will examine the prevalence and type of renal disease, the factors contributing to its growth, the change in trends in its diagnosis and treatment and the role of local, national and international healthcare organizations in the management and prevention of renal disease.


    2. Research design


    The research approach adopted in this study is qualitative in nature. Qualitative research is chosen due to the lack of quantitative data regarding the renal disease market and to obtain an in-depth understanding of the factors influencing its growth. This research design allows for a more detailed exploration and analysis of the current situation and the scope for further development.


    The need to collect primary and secondary data from a variety of sources is a crucial aspect of this research. To provide a comprehensive analysis of the topic, this work is based on interviews with health professionals and experts in the field of renal disease, a review of relevant literature and archived documents, online surveys and reports by various healthcare organizations. Secondary data collection will include industry reports and other resources.


    3. Sampling


    The demographic profile of the sample population varies depending on the specific source used. For example, interviews are conducted with qualified health professionals and experts who have experience with the diagnosis, treatment and management of renal disease, while surveys are designed to gain a broad representation of geographical regions, different income and social backgrounds, and an overall gender breakdown.


    4. Data collection


    The data collection process includes:



    • Interviews: This will be conducted with qualified health professionals and experts with experience in the diagnosis, treatment and management of renal disease. The interviews will last for around 30 minutes and will cover topics such as the prevalence and type of renal disease, the factors contributing to its growth, changes in trends in its diagnosis and treatment and the role of local, national and international healthcare organisations in the management and prevention of renal disease.

    • Archival documents: Information is collected from archived documents such as industry reports, national and international statistics and relevant literature.

    • Online surveys: This allows for a more general yet thorough analysis as respondents will be asked to provide detailed answers to questions on the current market situation, their personal experience and opinion on the growth of renal disease, and their views on the local, national and international policies highlighting the management and prevention of the disease.

    • Reports from healthcare organizations: Reports from both local and national healthcare organisations such as the Centers for Disease Control and Prevention (CDC) are consulted and included.


    5. Data analysis


    The data collected is analyzed using a variety of analytical and data processing techniques. Descriptive analyses will be used to present the overall picture of the renal disease market. The narrative analysis will be applied to examine the opinions and experiences of the interview and survey respondents. Qualitative data analysis is used to uncover the nuances and underlying motivations of the respondents. Regression analysis is employed to identify the correlations between different factors.


    6. Conclusion


    This study assesses the impact of renal disease on the global market. It is based on qualitative research that looks into the prevalence and type of renal disease, the factors contributing to its growth, changes in trends in its diagnosis and treatment and the role of local, national and international healthcare organisations in the management and prevention of renal disease. Primary data is obtained through interviews and surveys while secondary data will be collected from archived documents, industry reports and other resources. The data collected is analyzed through a variety of techniques with a particular focus on qualitative data analysis to identify the nuances and underlying motivations of the respondents.

    Market Size & Forecast

    Renal Disease Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 3.6 billion
    Market Size 2024 USD 3.9 billion
    Market Size 2032 USD 7.41 billion
    Compound Annual Growth Rate (CAGR) 9.7% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019-2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Disease Type, Treatment Type, End User and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Amgen Inc. (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (US), GlaxoSmithKline PLC (UK), Keryx Biopharmaceuticals, Inc. (US), Kissei Pharmaceutical Co., Ltd. (Japan), Novartis (Switzerland)
    Key Market Opportunities Growing geriatric population 
    Key Market Dynamics Increasing cases of diabetes and hypertension Rising prevalence of chronic kidney disease

    Major Players

    Renal Disease Market Segmentation

    Renal Disease Market Type Outlook (USD Billion, 2019-2030)

    • Chronic Kidney Disease

    • End-Stage Renal Disease

    Renal Disease Market Treatment Outlook (USD Billion, 2019-2030)

    • Dialysis

    • Medication

    • Kidney Transplantation

    Renal Disease Market End User Outlook (USD Billion, 2019-2030)

    • Dialysis Centers

    • Hospital & Clinics

    • Research and Academic Institutes

    Renal Disease Market Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • North America Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • North America Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • US Outlook (USD Billion, 2019-2030)

      • US Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • US Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • US Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Canada Outlook (USD Billion, 2019-2030)

      • Canada Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Canada Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Canada Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Europe Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Europe Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Germany Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Germany Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • France Outlook (USD Billion, 2019-2030)

      • France Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • France Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • France Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • UK Outlook (USD Billion, 2019-2030)

      • UK Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • UK Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • UK Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Italy Outlook (USD Billion, 2019-2030)

      • Italy Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Italy Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Italy Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Spain Outlook (USD Billion, 2019-2030)

      • Spain Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Spain Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Spain Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Rest Of Europe Outlook (USD Billion, 2019-2030)

      • Rest Of Europe Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Rest of Europe Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Rest of Europe Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Asia-Pacific Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Asia-Pacific Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • China Outlook (USD Billion, 2019-2030)

      • China Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • China Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • China Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Japan Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Japan Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • India Outlook (USD Billion, 2019-2030)

      • India Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • India Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • India Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Australia Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Australia Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • South Korea Outlook (USD Billion, 2019-2030)

      • South Korea Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • South Korea Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • South Korea Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Rest of Asia-Pacific Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Rest of Asia-Pacific Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Rest of the World Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Rest of the World Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Middle East Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Middle East Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Africa Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Africa Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Renal Disease Market by Type

        • Chronic Kidney Disease

        • End-Stage Renal Disease

      • Latin America Renal Disease Market by Treatment

        • Dialysis

        • Medication

        • Kidney Transplantation

      • Latin America Renal Disease Market by End User

        • Dialysis Centers

        • Hospital & Clinics

        • Research and Academic Institutes

    Market Trends

    Renal Disease Market Overview

    Renal Disease Market Valued at USD 3.6 billion in 2023, projected to grow from USD 3.9 billion in 2024 to USD 7.42 billion by 2032, with a CAGR of 9.70% during the forecast period (2024 - 2032).

    The increasing cases of diabetes & hypertension and the rising prevalence of chronic kidney disease are the key market drivers boosting the growth of the renal disease market.

    Renal Disease Market Overview Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    In October 2023, Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited (Sun Pharma) inked a licensing deal to jointly commercialize a novel pharmaceutical. The purpose of this collaboration is to enhance the treatment of patients suffering from anemia resulting from renal illness. Desidustat, according to its developers, is the inaugural oral pharmaceutical in India specifically designed to treat anemia resulting from chronic kidney disease (CKD). 

    Zydus has granted a semi-exclusive comarketing license to Sun Pharma for the RYTSTAT brand in India, as per the conditions of the agreement. Zydus debuted the medicine Oxemia under its brand name in 2022, and the business intends to continue its sales. Zydus will receive upfront license payments and further compensation upon achievin...

    Market Segment Insights

    Smartphone Sensors Smartphone Type Insights

    The Smartphone Sensors market segmentation, based on smartphone type, includes standard smartphone, rugged smartphone, smartwatches, and other wearable. The standard smartphone segment dominated the market, accounting for the maximum market revenue. A smartphone is a mobile phone with a built-in computer and advanced features, such as web browsing and operating system, which are not associated with its counterpart. The rising mobile internet use, rising disposable income in developing countries, and high ownership of premium design smartphones are a few factors that are anticipated to grow smartphone sales. Smartphones are helped by a mobile operating system that offers advanced computing facilities. A smartphone can also work as a digital media player for uploading photos, videos, and music through a single interface.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035
    Get detailed insights about Renal Disease Market

    Smartphone Sensors Manufacturer Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Application Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Regional Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035
    Get detailed insights about Smartphone Sensors Market

    Smartphone Sensors Price Insights

    The Smartphone Sensors market segmentation, based on price, includes USD 300 to USD 500, USD 100 to USD 300, above USD 500, and under USD 100. The USD 300 to USD 500 segment dominated the market revenue in the projected period. Most smartphones sold in medium-end devices have a sensor within this range. For instance: Nubia launched a new flagship Android device powered by the latest Snapdragon 8Gen 2CPU. The OEM has also specified that this gadget, which peculiarly seems to go by the name Z50 even though its processor was the z40 Pro, will compete with the Xiaomi 13 and iQOO11 series with cutting-edge LPDDR5X RAM and storage with the most recent UFS 4.0 spec.

    Get more detailed insights about Renal Disease Market

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development to expand their product lines, which will help the Smartphone Sensors market, grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and growing market climate, the Smartphone Sensors industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Smartphone Sensors industry to benefit clients and increase the market sector. In recent years, the Smartphone Sensors industry has offered manufacturers some of the most significant advantages. Major players in the Smartphone Sensors market, including MS AG (Austria), Broadcom Inc. (US), DYNA IMAGE Corporation (China), Murata Electronics Oy (Finland), NEXT Biometrics Group ASA (Norway), Omron Corporation (Japan), Samsung Electronics Co. Ltd. (South Korea), Sony Corporation (Japan)., and others, are attempting to increase market demand by investing in research and development operations.

    Samsung is dedicated to abiding by local laws and regulations and enforcing a strict code of conduct for all employees. Samsung adheres to a straightforward business tent: to usage its technology and expertise to develop top-notch goods and services that make a more cultured world. Samsung provides a high importance on its people and technologies to do this. For Instance: In January 2023, Samsung Electronics launched its new MICRO LED, Neo QLED, and Samsung OLED product lines, along with lifestyle products and accessories, before CES® 2023.

    Apple Inc. is a multinational American technology business with its main office in Cupertino, California. According to revenue, Apple will be the top technological business in the world in 2022, with US $ 394.3 billion in sales. According to market capitalization, Apple is the largest corporation in the world as of March 2023. For Instance: In September 2022, the iPhone 14 and iPhone 14 Plus, which come in two sizes, 6.1 and 6.7 inches and include a smart design, camera upgrades, and game-changing new safety measures, were introduced by Apple. The iPhone 14 and iPhone 14 Plus have a powerful camera system that incorporates the primary and front TrueDepth cameras, the Ultra Wide camera for uncommon perspectives, and the photonic engine, an enhanced picture pipeline.

    Key Companies in the Smartphone Sensors market include

    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)

    Industry Developments

    • September 2022: Comcast and Samsung Electronics announced their partnership to create 5G Radio Access Network (RAN) technologies to enhance 5G connection for Xfinity Mobile and Comcast Business Mobile users in Comcast service zones. Samsung will provide 5G RAN technology, and Comcast will deploy Citizens Broadband Radio Service (CBRS) and 600 MHz spectrum to provide 5G access to consumer and business users in the US.
    • October 2022: Huawei announced the release of the newest antenna solutions, including the Maxwell platform and the X2 antenna series, for the subsequent 5G antenna innovation stage. The new technologies speed up 5G deployment by improving antenna and setup capabilities.

    Market Segmentation

    Smartphone Type Outlook

    • Standard Smartphone
    • Rugged Smartphone
    • Smartwatches
    • Other Wearable

    Price Outlook

    • USD 300 to USD 500
    • USD 100 to USD 300
    • Above USD 500
    • Under USD 100

    Manufacturer Outlook

    • Apple Inc.
    • Samsung Electronics
    • Huawei Technology
    • Xiaomi Inc.
    • Oppo
    • Sony Corporation
    • HMD Global

    Application Outlook

    • High-Level
    • Mid-Level
    • Low-Level

    Manufacturer Outlook

    North America
    • US
    • Canada
    Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    Asia-Pacific
    • China
    • Japan
    • India
    • Italy
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    Rest of the World
    • Middle East
    • Africa
    • Latin America

    Report Scope

    Renal Disease Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 3.6 billion
    Market Size 2024 USD 3.9 billion
    Market Size 2032 USD 7.41 billion
    Compound Annual Growth Rate (CAGR) 9.7% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019-2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Disease Type, Treatment Type, End User and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Amgen Inc. (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (US), GlaxoSmithKline PLC (UK), Keryx Biopharmaceuticals, Inc. (US), Kissei Pharmaceutical Co., Ltd. (Japan), Novartis (Switzerland)
    Key Market Opportunities Growing geriatric population 
    Key Market Dynamics Increasing cases of diabetes and hypertension Rising prevalence of chronic kidney disease

    Market Highlights

    Author

    Aarti Dhapte
    Team Lead - Research

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    At what CAGR is the global renal disease market projected to grow in the forecast period (2018-2023)?

    Renal disease market projected to grow at approximately 6.32% CAGR during the assessment period (2018-2023).

    How much is the global renal disease market worth in the future?

    The valuation of the global renal disease market is estimated to increase to USD 133,451.06 MN by the end of 2023.

    What are the major tailwinds pushing the growth of the global renal disease market?

    Growth in the prevalence of kidney diseases and the rising government funding for R&D & initiatives to spread the awareness, are major tailwinds pushing the growth of the global renal disease market.

    Which region holds the largest share in the global renal disease market?

    North America holds the largest share in the global renal disease market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global renal disease market?

    Amgen Inc. (US), AstraZeneca (US), Abbott (US), Bristol-Myers Squibb Company (US), Fresenius Medical Care AG & Co. KGaA (UK), Teva Pharmaceutical Industries Ltd (Israel), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline PLC (UK), Kissei Pharmaceutical Co., Ltd (Japan), Keryx Biopharmaceuticals, Inc. (US), Pfizer Inc. (US), Novartis AG (Switzerland), and Sanofi SA (France), are some of the top players operating in the global renal disease market.

    1. Market Introduction
      1. Scope of Study
      2. Research Objective 17
      3. List of Assumptions 18
    2. Research
      1. Research Process 20
      2. Primary Research 21
      3. Secondary
      4. Market Size Estimation 23
    3. Market Dynamics
      1. Introduction
      2. Drivers 25
        1. Rising Prevalence of Kidney Disease 25
        2. Rapid Growth in the
      3. Restraints 26
        1. Rising Healthcare Cost
        2. Stringent Regulatory Policies 26
      4. Opportunities 26
      5. Market Trends 26
        1. Artificial
      6. Macroeconomic Indicators 27
    4. Market Factor Analysis
      1. Porter’s
        1. Bargaining Power of Suppliers 28
        2. Bargaining
        3. Threat of New Entrants 29
        4. Threat of Substitutes
        5. Intensity of Rivalry 29
      2. Value Chain Analysis 30
        1. Manufacturing 30
        2. Distribution and
        3. Post-Sales Services 31
      3. Pricing Analysis 31
    5. Renal Disease Market, By Disease Type
      1. Chronic Kidney Disease 34
      2. End-Stage Renal Disease
    6. Renal Disease Market, By Treatment Type
      1. Overview 36
      2. Dialysis 37
      3. Medication 38
      4. Kidney Transplantation 40
      5. Overview 41
      6. Dialysis Centres
      7. Hospital & Clinics 43
      8. Research and Academic Institutes
    7. Global Renal Disease Market, by Region
      1. Overview 45
      2. Americas
        1. North America 50
        2. Latin America 58
      3. Europe 61
        1. Western Europe
        2. Eastern Europe 83
      4. Asia-Pacific 86
        1. Japan 89
        2. China 92
        3. India 94
        4. South Korea 97
        5. Australia 99
        6. Rest of Asia-Pacific 102
      5. Middle East & Africa 105
        1. Middle East 108
        2. Africa 111
      6. Introduction 114
    8. Company Profiles
      1. Amgen Inc. 118
        1. Financial Overview 118
        2. Products/Services
        3. Key Developments 119
        4. SWOT Analysis 120
      2. AstraZeneca 121
        1. Company Overview 121
        2. Financial Overview 121
        3. Products/Services Offered 122
        4. SWOT Analysis 123
        5. Key Strategies 123
      3. Bristol-Myers Squibb Company 124
        1. Company Overview 124
        2. Products/Services Offered 124
        3. Key
        4. SWOT Analysis 125
        5. Key Strategies 125
      4. F. Hoffmann-La Roche Ltd 126
        1. Company Overview 126
        2. Products/Services Offered 127
        3. Key
        4. SWOT Analysis 127
        5. Key Strategies 127
      5. Fresenius Medical Care AG & Co. KGaA 128
        1. Company Overview
        2. Financial Overview 128
        3. Products/Services Offered 129
        4. Key Developments 129
        5. SWOT Analysis 130
        6. Key Strategies
      6. GlaxoSmithKline PLC 131
        1. Company Overview 131
        2. Products/Services Offered 131
        3. Key
        4. SWOT Analysis 132
        5. Key Strategies 132
      7. Keryx Biopharmaceuticals, Inc. 133
        1. Company Overview 133
        2. Products/Services Offered 133
        3. Key
        4. SWOT Analysis 134
        5. Key Strategies 134
      8. Kissei Pharmaceutical Co., Ltd 135
        1. Company Overview 135
        2. Products/Services Offered 135
        3. Key
        4. SWOT Analysis 136
        5. Key Strategies 136
      9. Novartis AG 137
        1. Company Overview 137
        2. Financial
        3. Products/Services Offered 137
        4. Key Developments
        5. SWOT Analysis 138
        6. Key Strategies 138
      10. Pfizer
        1. Company Overview 139
        2. Financial Overview 139
        3. Products/Services Offered 140
        4. Key Developments 140
        5. Key Strategies 140
      11. Sanofi SA 141
        1. Financial Overview 141
        2. Products/Services
        3. Key Developments 142
        4. SWOT Analysis 142
        5. Key Strategies 142
      12. Teva Pharmaceutical Industries Ltd 143
        1. Company Overview 143
        2. Financial Overview 143
        3. Key Developments 144
        4. SWOT
        5. Key Strategies 144
    9. Appendix
      1. Discussion
    10. List of Tables
    11. LIST OF ASSUMPTIONS 18
    12. GLOBAL RENAL DISEASE MARKET, FOR KIDNEY TRANSPLANTATION, BY REGION, 2023-2030
    13. AMERICAS: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 50
    14. NORTH AMERICA: RENAL DISEASE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 50
    15. WESTERN EUROPE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION)
    16. WESTERN EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 67
    17. FRANCE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030
    18. REST OF WESTERN EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION)
    19. CHINA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION)
    20. AUSTRALIA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 99
    21. REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION)
    22. MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030
    23. TOP MANUFACTURERS IN THE GLOBAL RENAL DISEASE MARKET 115
    24. List of Figures

    Renal Disease Market Segmentation

    Renal Disease Market Type Outlook (USD Billion, 2019-2030)

    • Chronic Kidney Disease
    • End-Stage Renal Disease

    Renal Disease Market Treatment Outlook (USD Billion, 2019-2030)

    • Dialysis
    • Medication
    • Kidney Transplantation

    Renal Disease Market End User Outlook (USD Billion, 2019-2030)

    • Dialysis Centers
    • Hospital & Clinics
    • Research and Academic Institutes

    Renal Disease Market Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • North America Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • North America Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • US Outlook (USD Billion, 2019-2030)

      • US Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • US Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • US Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Canada Outlook (USD Billion, 2019-2030)

      • Canada Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Canada Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Canada Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Europe Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Europe Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Germany Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Germany Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • France Outlook (USD Billion, 2019-2030)

      • France Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • France Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • France Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • UK Outlook (USD Billion, 2019-2030)

      • UK Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • UK Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • UK Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Italy Outlook (USD Billion, 2019-2030)

      • Italy Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Italy Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Italy Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Spain Outlook (USD Billion, 2019-2030)

      • Spain Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Spain Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Spain Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Rest Of Europe Outlook (USD Billion, 2019-2030)

      • Rest Of Europe Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Rest of Europe Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Rest of Europe Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Asia-Pacific Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Asia-Pacific Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • China Outlook (USD Billion, 2019-2030)

      • China Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • China Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • China Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Japan Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Japan Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • India Outlook (USD Billion, 2019-2030)

      • India Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • India Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • India Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Australia Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Australia Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • South Korea Outlook (USD Billion, 2019-2030)

      • South Korea Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • South Korea Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • South Korea Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Rest of Asia-Pacific Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Rest of Asia-Pacific Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Rest of the World Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Rest of the World Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Middle East Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Middle East Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Africa Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Africa Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes

      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Renal Disease Market by Type
        • Chronic Kidney Disease
        • End-Stage Renal Disease
      • Latin America Renal Disease Market by Treatment
        • Dialysis
        • Medication
        • Kidney Transplantation
      • Latin America Renal Disease Market by End User
        • Dialysis Centers
        • Hospital & Clinics
        • Research and Academic Institutes
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Global Reports
    Regional Reports
    Country Reports

    Customer Strories

    Watch Video

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Jongwon Byun

    Director, Research Operations
    Case Study

    Smartphone Motherboard Parts Manufacturing Research

    Smartphone Motherboard Parts Manufacturing Research